Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Intensive Care Medicine
Literature
1.
2.
Oostdijk EA, Smits L, de Smet AM, Leverstein-van Hall MA, Kesecioglu J, Bonten MJ (2013) Colistin resistance in gram-negative bacteria during prophylactic topical colistin use in intensive care units. Intensive Care Med 39(4):653–660PubMedCrossRef
3.
Daneman N, Sarwar S, Fowler RA, Cuthbertson BH, Su DCSG (2013) Effect of selective decontamination on antimicrobial resistance in intensive care units: a systematic review and meta-analysis. Lancet Infect Dis 13(4):328–341PubMedCrossRef
4.
Halaby T, Al Naiemi N, Kluytmans J, van der Palen J, Vandenbroucke-Grauls CM (2013) Emergence of colistin resistance in Enterobacteriaceae after the introduction of selective digestive tract decontamination in an intensive care unit. Antimicrob Agents Chemother 57(7):3224–3229PubMedCentralPubMedCrossRef
5.
Lübbert C, Faucheux S, Becker-Rux D, Laudi S, Durrbeck A, Busch T, Gastmeier P, Eckmanns T, Rodloff AC, Kaisers UX (2013) Rapid emergence of secondary resistance to gentamicin and colistin following selective digestive decontamination in patients with KPC-2-producing Klebsiella pneumoniae: a single-centre experience. Int J Antimicrob Agents 42(6):565–570PubMedCrossRef
6.
Munoz-Price LS, Poirel L, Bonomo RA, Schwaber MJ, Daikos GL, Cormican M, Cornaglia G, Garau J, Gniadkowski M, Hayden MK, Kumarasamy K, Livermore DM, Maya JJ, Nordmann P, Patel JB, Paterson DL, Pitout J, Villegas MV, Wang H, Woodford N, Quinn JP (2013) Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis 13(9):785–796PubMedCrossRef
Metadata
Title
SDD and colistin resistance: end of a dream?
Authors
Matteo Bassetti
Elda Righi
Publication date
01-07-2014
Publisher
Springer Berlin Heidelberg
Published in
Intensive Care Medicine / Issue 7/2014
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-014-3328-2

Other articles of this Issue 7/2014

Intensive Care Medicine 7/2014 Go to the issue

What's New in Intensive Care

In pursuit of pain: recent advances and future directions in pain assessment in the ICU

Letter

Noninvasive ventilation in blunt chest trauma: beware of missed esophageal injuries!

My Paper 20 Years Later

My paper 20 years later: Effect of positive end-expiratory pressure on right ventricular function in humans

Correspondence

Colistin, SDD and resistance: nihil novi sub sole

Editorial

Candidemia and non-candidemia related septic shock: are there differences between them?

Original

Helmet CPAP vs. oxygen therapy in severe hypoxemic respiratory failure due to pneumonia